brivanib
"Brivanib has been investigated for the treatment of Solid Tumors, Hepato Cellular Carcinoma (HCC), and Metastatic Colorectal Cancer (MCRC). It is under investigation for the treatment of HepatoCellular Carcinoma. . Reference standards of Brivanib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => Brivanib
[catalogue_number] => PA 02 45000
[category_ids] => ,69,78,70,82,89,
[chemical_name] =>
[weight] => 370.38
[form] => C19H19FN4O3
[cas] => 649735-46-6
[pslug] => 649735-46-6-brivanib-api-pa0245000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 02 45000
Molecular Formula : C19H19FN4O3
Molecular Weight : 370.38